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Objective: Equilibrium Partitioning of an Ionic Contrast agent with microcomputed tomography (EPIC-
mCT) is a non-invasive technique to quantify and visualize the three-dimensional distribution of
glycosaminoglycans (GAGs) in fresh cartilage tissue. However, it is unclear whether this technique is
applicable to already ﬁxed tissues. Therefore, this study aimed at investigating whether formalin ﬁxation
of bovine cartilage affects X-ray attenuation, and thus the interpretation of EPIC-mCT data.
Design: Osteochondral samples (n¼ 24) were incubated with ioxaglate, an ionic contrast agent, for 22 h
prior to mCT scanning. The samples were scanned in both formalin-ﬁxed and fresh conditions. GAG
content was measured using a biochemical assay and normalized to wet weight, dry weight, and water
content to determine potential reasons for differences in X-ray attenuation.
Results: The expected zonal distribution of contrast agent/GAGs was observed for both ﬁxed and fresh
cartilage specimens. However, despite no signiﬁcant differences in GAG concentrations or physical
properties between ﬁxed and fresh samples, the average attenuation levels of formalin-ﬁxed cartilage
were 14.3% lower than in fresh samples.
Conclusions: EPIC-mCT is useful for three-dimensional visualization of GAGs in formalin-ﬁxed cartilage.
However, a signiﬁcant reduction in X-ray attenuation for ﬁxed (compared to fresh) cartilage must be
taken into account and adjusted for accordingly when quantifying GAG concentrations using EPIC-mCT.
 2010 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.Introduction
Glycosaminoglycans (GAGs) are one of the most important
constituents of articular cartilage. They provide a net negative
charge and aid the cartilage in resisting the large compressive loads
to which it is exposed on a daily basis1. GAGs vary in concentration
throughout the depth of articular cartilage, with low concentration
in the superﬁcial zone and increasing concentrations in the middle
and deep zones2. These variations are functionally important, as
they allow for compliant articular surfaces, and a relatively smooth
transition to the stiffer calciﬁed cartilage and subchondral bone3.
GAG levels are known to decrease in early osteoarthritis (OA)1,4 and
are an early indicator of degradation of cartilage tissue and loss ofT.J. Klein, Institute of Health
Technology, 60 Musk Avenue,
2; Fax: 61-7-3138-6030.
s Research Society International. Pjoint function. Further, the GAG content and distribution in in vitro
cultured tissues may be a key to developing successful tissue
engineered cartilage constructs to replace damaged or degenerated
cartilage5. Thus, knowledge of GAG concentration and distribution
in native and tissue-engineered cartilage is fundamentally impor-
tant to understand the onset and progression of cartilage disease
and to develop successful regenerative treatment strategies.
GAG content and distribution in cartilaginous tissues have most
commonly been monitored using destructive methods. Typically,
small cartilage biopsies are taken, sectioned and mounted on glass
slides, after which GAG content is visualized using histological
stains, such as Safranin O6, Alcian blue7, or Toluidine blue8. These
techniques are invasive, creating a defect in clinical situations, and
only give two-dimensional information on a relatively small section
of the tissue, which may not be representative of the whole tissue.
While there have been efforts to make some of the histological
methods quantitative using image processing techniques9, they are
generally qualitative in nature. For quantiﬁcation of the GAGublished by Elsevier Ltd. All rights reserved.
Fig. 1. Diagram of experimental protocol for EPIC-mCT imaging of the three
experimental groups. Samples in Group I were scanned directly after incubation with
ioxaglate. Samples in Group II were ﬁxed prior to ioxaglate incubation and scanning.
Samples in Group III were ﬁrst imaged as samples in Group I, then washed in PBS,
ﬁxed, incubated with ioxaglate and imaged again.
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enzyme (e.g., papain or proteinase K), and analysed using a spec-
trophotometric method with a speciﬁc dye (typically dimethyl-
methylene blue)10. This method is the gold standard for
quantiﬁcation, but the distribution of GAGs throughout the depth
of the tissue is difﬁcult to obtain.
In the past decade, non-invasive means to quantify GAG content
have been developed to overcome the limitations of destructive
tests. For example, magnetic resonance imaging (MRI) in combi-
nation with a gadolinium contrast agent, a technique referred to as
delayed Gadolinium-Enhanced MRI of Cartilage (dGEMRIC), has
been shown to be effective in measuring GAG content of articular
cartilage11e13. However, MR imaging is a costly process and often
does not provide a high enough resolutionwhen looking at thinner
layers of cartilage in smaller animals such as rats or mice14. This
also poses a problem when imaging thin layers of in vitro cultured
cartilage constructs. GAG content and zonal variations can also be
studied by means of microcomputed tomography (mCT) combined
with the contrast agent ioxaglate (Hexabrix). This method, termed
Equilibrium Partitioning of an Ionic Contrast agent (EPIC) mCT14e17,
is based on the distribution of the contrast agent, which is inversely
related to the amount of GAGs in the cartilage. It can hence be used
to quantify GAG content even in thin cartilage samples18. In
particular, a strong correlation between EPIC-mCTattenuation levels
and GAG content measured in digested tissues was observed15.
Further, EPIC-mCT has been used to monitor the decrease of GAG
content of bovine cartilage explants after treatment with inter-
leukin-1 (IL-1)15, as well as age-related differences in GAG content
in the articular cartilage of rats17. The latter study demonstrated
that the GAG differences can be detected by EPIC-mCT, not only in
thick cartilage layers, but also in thin cartilage layers e.g., present in
smaller animal models.
Thus far, GAG content has only been quantiﬁed by EPIC-mCT
using freshly harvested specimens, rather than formalin-ﬁxed
ones14,15,17,19. For EPIC-mCT, fresh samples must be scanned imme-
diately after excision, limiting the settings in which this technology
can be used. The ability to use formalin-ﬁxed samples would offer
the opportunity of non-invasive GAG quantiﬁcation of multiple
samples over more extensive periods of time. Moreover, degrada-
tion of the proteoglycan network would be prevented, facilitating
easier sample handling. Further, pre-ﬁxed archival samples could
be analysed to determine three-dimensional (3D) GAG concentra-
tion and distribution. Thus, extension of EPIC-mCT to formalin-ﬁxed
samples would have signiﬁcant impact on the high resolution
quantiﬁcation of GAG content and distribution in a broad range of
small and large cartilage samples. Therefore, we evaluated the
effect of formalin ﬁxation on EPIC-mCT imaging in bovine cartilage
samples.
Materials and methods
Design and tissue harvest
Adult bovine osteochondral tissue was obtained from a local
abattoir. Twenty-four osteochondral fragments of approximately
3 mm 5 mm were obtained from the trochlear groove using
a hacksaw, with phosphate buffered saline (PBS) irrigation. The
fragments were stored overnight at 4C in PBS with protease
inhibitors (2 mM Na2-EDTA, 1 mM PMSF, 5 mM Benz-HCl, 10 mM
NEM) (all SigmaeAldrich, St. Louis, MO, USA) to prevent degrada-
tion. The osteochondral samples were divided into three groups
(Group I, Group II, Group IIIa and Group IIIb). All samples were
incubated in 1 mL of an ionic contrast agent solution (1 mL 40%
ioxaglate (Hexabrix, Mallingckrodt, Hazelwood, MO)/60% PBS
with protease inhibitors) for 22 h at 37C with continuous shakingimmediately prior to imaging. This time was shown previously to
be sufﬁcient for reaching equilibrium15, and was veriﬁed by pilot
studies. Group I was incubated directly with ioxaglate and scanned
immediately afterwards. Group II was ﬁrst ﬁxed in 10% neutral
buffered formalin for 48 h, incubated in ioxaglate and then scan-
ned. Group III was incubated immediately with ioxaglate (like
Group I) and scanned (Group IIIa). Subsequently, the samples were
incubated in PBS at 4C for 48 h to allow for ioxaglate desorption.
Then, the samples were ﬁxed in 10% neutral buffered formalin for
48 h, incubated in ioxaglate for a second time and scanned (Group
IIIb) (Fig. 1). This allowed us to study the intra-group variation of
attenuation levels before and after formalin ﬁxation.
From each of the groups, ﬁve samples were randomly selected
for biochemical GAG analysis. The three remaining samples from
Group II were used for Safranin O staining. The remnants of the
proteinase K digestion of the ﬁxed samples were also used for
Safranin O staining.
MicroCT
MicroCT scanning was performed at standard resolution in the
mCT40 (ScancoMedical, Brüttisellen, Switzerland) at 45 kVp,177 mA,
resulting in 12 mm isotropic voxel size. Scanco mCT software (Scanco
Medical, Brüttisellen, Switzerland) was used for the analysis
of the osteochondral cores. A cubic volume of interest
(2 mm 2 mm cartilage thickness) was deﬁned, and threshold
values were determined visually for segmenting the cartilage from
the osteochondral bone, using aGaussianﬁlterwith sigmaof 1.2 and
a support of 2. Attenuation levels (presented in Hounsﬁeld Units
(HU)), which are proportional to the concentration of ioxaglate and
inversely related to the GAG concentration15, were calculated using
the Scanco software. Three-dimensional images of the osteochon-
dral fragments were generated using the Scanco software for visual
inspection of the zonal distribution of GAG concentration. Addi-
tionally, attenuation levels from 2 mm 2 mm 0.012 mm slices
from the top 20% (superﬁcial zone), next 40% (middle zone), and
bottom 40% (deep zone) were averaged for a representative sample
from Group III before and after ﬁxation to further investigate zonal
differences in attenuation. The cartilage thickness before and after
ﬁxation was calculated using a direct distance transformation
algorithm20. Further, the change of thickness was also evaluated by
a shell-to-shell comparison of a single sample from Group III. A
Fig. 2. Safranin O staining of (A) ﬁxed bovine osteochondral explant and (B) ﬁxed
bovine articular cartilage following overnight digestion with proteinase K. Safranin O
stains GAG red, Fast Green FCF stains proteins green and haematoxylin stains nuclei
blue. GAG staining was depth-dependent in (A) ﬁxed bovine cartilage but not observed
in (B) proteinase K digested bovine cartilage.
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created by aligning and comparing STLﬁles of a 1 mmcross-section,
scanned before and after ﬁxation, using Rapidform 2006 (INUS
Technology Inc., Seoul, Korea).
Histology
Samples from Group II and Group III were used for Safranin O
staining. Samples were decalciﬁed in EDTA (SigmaeAldrich) before
they were dehydrated through a graded ethanol series, cleared in
xylene and embedded in parafﬁn. Embedded samples were
sectioned to yield 5 mm sections, which were stained using a triple
stain of haematoxylin, fast green FCF (0.001% w/v) and Safranin O
(0.1% w/v) (all from SigmaeAldrich). The sections were examined
using a light microscope (Olympus, BX51, USA) and photomicro-
graphs taken with a Olympus DP70 camera (USA).
Wet weight/dry weight
For the determination of the wet and dry weight, articular
cartilage samples were separated from all the visible subchondral
bone using a scalpel (n¼ 5 per group), and weighed (wet weight).
Subsequently, samples were snap frozen in liquid nitrogen,
lyophilized (Martin-Christ, Germany), and weighed (dry weight).
GAG assay
Lyophilized cartilage samples were digested with 0.5 mg/mL
proteinase K (Invitrogen, Carlsbad, USA) at 60C overnight. Absor-
bance was measured at 525 nm in a microplate reader (Biorad,
Philadelphia, USA) after reaction with dimethylmethylene blue
(SigmaeAldrich), and GAG content was calculated using a standard
of chondroitin sulfate C (SigmaeAldrich)10.
Statistical analysis
Statistical comparisons were made using a two-tailed Student’s
t-test with signiﬁcance determined by a P-value smaller than 0.05.
For comparisons of samples scanned before and after ﬁxation
(Group III), paired t-tests were used. All data are represented as
mean and 95% conﬁdence interval (lower limit, upper limit).
Analysis of variance (ANOVA) was used to compare Group I, Group
II and Group III with signiﬁcance determined by a P-value smaller
than 0.05.
Results
The presence and zonal distribution of GAGs throughout the
bovine articular cartilage tissue samples was conﬁrmed by means
of Safranin O staining [Fig. 2(A)], which is directly proportional to
the GAG content9. The intensity of the staining in the cartilage
tissue increased from the superﬁcial layer towards the deeper
layers.
The average attenuation, as an indirect measure of overall GAG
content of the unﬁxed samples, did not signiﬁcantly differ between
Group I and Group IIIa (n¼ 8, 3667.3 (3357.6e3977.0) HU vs 3618.1
(3248.0e3988.1) HU, P¼ 0.66). However, ﬁxation prior to EPIC-mCT
imaging (Group II) resulted in a signiﬁcant decrease of the atten-
uation by 14.3% compared to that of unﬁxed samples (Group I)
(n¼ 8, 3142.2 (2812.8e3471.5) HU vs 3667.3 (3357.6e3977.0) HU,
P< 0.001). In line, the average attenuation of Group III decreased
signiﬁcantly after ﬁxation (n¼ 8, 3618.1 (3248.0, 3988.1) vs 3317.6
(2953.2e3682.1) HU, P< 0.05).
A zonal distribution of GAGs was observed in fresh and ﬁxed
cartilage using EPIC-mCT imaging (Fig. 3). However, as a result of thedifferences in overall cartilage attenuation between the ﬁxed and
unﬁxed samples, the output ranges needed to be adjusted for
optimal visualization of the 3D zonal distribution of GAGs. Output
ranges of 1748e4851 HU for freshly scanned samples [Fig. 3(A)] and
1748e3871 HU for ﬁxed samples [Fig. 3(D)] resulted in similar
images of the zonal GAG distribution [Fig. 3(A, D)]. The difference in
attenuation between the superﬁcial (top 20%) and middle (20e60%
of depth) zones of a representative sample from Group III was 12%
(14% after ﬁxation), and 28% (28% after ﬁxation) between the
superﬁcial and deep (bottom 40%) zones [Fig. 3(E)]. The attenuation
level was consistently lower throughout the depth of cartilage after
ﬁxation, as demonstrated by similar reductions of attenuation in
the superﬁcial (top 20%), middle (20e60%) and deep (bottom 40%)
zones [Fig. 3(E)].
To evaluatewhether differences in GAG content, wet weight, dry
weight, or cartilage thickness had contributed to the observed
differences in attenuation levels betweenﬁxedandunﬁxed samples,
thesewere determined for all experimental groups. Thewet and dry
weights of unﬁxed samples (Group I)werenot signiﬁcantlydifferent
from the groups that were ﬁxed during this experiment (Group II
and Group III) [Fig. 4(A)]. In addition, imaging of Group III revealed
that average cartilage thickness, as determined from the mCT data,
was not affected signiﬁcantly by the subsequent ﬁxation (n¼ 8,1.39
(1.32, 1.46) mm, vs 1.48 (1.37, 1.59) mm, P¼ 0.15). Shell-to-shell
comparisons of samples from Group III before and after ﬁxation,
showed a difference in thickness of 0.04 mm [Fig. 4(B)], which
indicates a change in volume of less than 5%.
Moreover, biochemical quantiﬁcation of GAGs (Table I) revealed
similar levels in fresh (Group I) and ﬁxed tissues (Group II and
Group IIIb), whilst Safranin O staining of ﬁxed and subsequently
digested samples conﬁrmed the absence of residual GAGs [Fig. 2
(B)]. Further, no signiﬁcant differences in the average amount of
GAG per dry weight could be determined between the groups
(Table I).
Fig. 3. Two-dimensional representations of three-dimensional attenuation values present in (A, B) fresh and (C, D) ﬁxed osteochondral samples. Different attenuation value ranges
were chosen to show the greatest range from superﬁcial to deep zones in (A) fresh and (D) ﬁxed tissues. Clear differences in attenuation values can be seen when (B) fresh samples
are displayed in the ﬁxed range, and (C) ﬁxed samples are displayed in the fresh range. After adjusting the attenuation value ranges, images (A) fresh and (D) ﬁxed show the optimal
representation of GAG distribution in both fresh and ﬁxed cartilage tissues. Low attenuation (blue) indicates high GAG concentration, high attenuation (red) indicates low GAG
concentration. (E) Attenuation values in different zones (mean with 95% CI, n¼ 20 slices for superﬁcial (S), 40 slices for middle (M), and 40 slices for deep (D) zones) for
a representative sample from Group III before and after ﬁxation.
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We have shown that the non-destructive imaging technique,
EPIC-mCT, can be used to detect zonal differences in GAG content
in both fresh and formalin-ﬁxed articular cartilage explants.
Previous studies have shown that EPIC-mCT is a valuable 3D tool
for quantiﬁcation of GAG levels in the different zones of fresh
articular cartilage14,15,17. However, there are multiple beneﬁts to
using formalin-ﬁxed tissue, including prevention of matrix degra-
dation, simpliﬁcation and standardization of sample processing,
and allowing for analysis of GAG content and distribution inFig. 4. (A) Weights of water and dry cartilage content in Group I (n¼ 5), Group II (n¼ 5),
unpaired t-test. Error bars represent 95% CI. Comparison of cartilage microCT surfaces of a r
surface on top, cut surfaces on the sides, and cartilageebone boundary on the bottom. Colo
distribution of differences between scans shows an average surface deviation of 0.02 mm,already-ﬁxed or archival samples. Thus, thiswork extends the realm
of applications for EPIC-mCT.
One major ﬁnding of our study is that formalin ﬁxation
decreases X-ray attenuation levels in ioxaglate-stained cartilage.
This was apparent in both the average attenuation values (Fig. 3)
and depth-dependent attenuation values (Fig. 4). As the amount of
ioxaglate is inversely related to the amount of GAGs15, one could
reach the conclusion that ﬁxed tissues contain a higher concen-
tration of GAGs than fresh tissues. While this could potentially be
the case, the samples in Group III, which were both scanned fresh
and after ﬁxation, showed lower attenuation levels after ﬁxation,and Group III (n¼ 5) (after ﬁxation). No signiﬁcant differences were found using an
epresentative sample from Group III. (B) A 1 mm thick section is shown, with articular
r intensity represents the variation between surfaces of the fresh and ﬁxed scans. The
corresponding to a change in thickness of 0.04 mm.
Table I
Biochemically quantiﬁed GAG content of bovine samples. GAG content of Group I
(n¼ 5), Group II (n¼ 5) and Group IIIb (n¼ 5) bovine samples shown as mean and
95% conﬁdence interval of the GAG content per wet weight (ww), dry weight (dw)
and water. No signiﬁcant differences were found between the experimental groups
using unpaired t-tests, with P-values comparing respective groups listed below the
mean and conﬁdence interval
Group I Group II Group IIIb
GAG/ww
(mg/mg)
32.9 (30.5, 35.3)
P¼ 0.28, 0.50
35.6 (31.8, 39.4)
P¼ 0.28, 0.83
36.9 (26.2, 47.6)
P¼ 0.50, 0.83
GAG/dw
(mg/mg)
165.3 (151.7, 178.8)
P¼ 0.99, 0.88
165.3 (141.8, 188.9)
P¼ 0.99, 0.89
168.9 (126.8, 211.0)
P¼ 0.89, 0.88
GAG/H2O
(mg/mg)
41.2 (37.7, 44.7)
P¼ 0.19, 0.44
45.4 (40.8, 50.0)
P¼ 0.19, 0.81
47.2 (33.0, 61.5)
P¼ 0.44, 0.81
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To gain further insight into the potential causes for the observed
differences in attenuation between the fresh and ﬁxed samples,
several potential explanations for the differences were studied. The
ﬁrst possible explanation is that the GAG content was higher in the
ﬁxed tissues, potentially caused by GAG loss in the fresh tissues.
Therefore,wequantiﬁedtheamountofGAGs inthesamplesbymeans
of a biochemical assay following proteinase K digestion of the tissues.
To the best of our knowledge there are no data on the degradation of
ﬁxed cartilage tissue by proteinase K. However, other tissues such as
lung tissue have successfully been released after ﬁxation using
proteinase K21. Safranin O staining revealed that proteinase K diges-
tion of the ﬁxed cartilage tissue was adequate since positive staining
for GAGs was absent in the residual tissue after digestion (Fig. 1). The
total GAG content of the tissue (relative to dryweight, wetweight, or
water) did not signiﬁcantly vary between the fresh and ﬁxed samples
anddifferences in attenuation levels can, therefore,most likely not be
explained by differences in GAG content.
A second possible explanation for the observed differences in
attenuation could be a variation in water content between the
experimental groups. Ioxaglate accumulates in the water
compartment of cartilage during incubation. Thus, if the water
content in fresh samples is higher than in ﬁxed samples, due to
volumetric changes, for example, the amount of ioxaglate in the
ﬁxed samples could be lower. No signiﬁcant differences in cartilage
thickness, determined by mCT, were observed within Group III
before and after ﬁxation, but small observed differences in volume
(w5%) may account for some of the differences in attenuation. Our
results also show that there is no signiﬁcant difference between the
water content of fresh samples (Group I, n¼ 5) and the ﬁxed
samples (Group II and Group III, n¼ 10). Thus, changes in water
content and geometry are not likely to be the sole cause for the
observed differences in attenuation levels.
An alternative explanation for the lower attenuation in ﬁxed
tissues is that the diffusion of ioxaglate is hindered in ﬁxed tissues
due to a tighter extracellular matrix network, and thus a longer
incubation is needed to reach equilibrium. EPIC-mCT relies on the
principle of equilibrium of the ionic contrast agent15,17 and thus it is
important to reach equilibrium when using this technique.
However, attenuation levels of ﬁxed tissues stained for 72 h
remained unchanged from those stained for 22 h, and lower than
the fresh tissues (data not shown). Formalin ﬁxation has been
shown to form strong and stable methylene cross-links with amino,
amide and guanidyl groups as well as aromatic amino acids. This
means that formalin would cross-link the NH-groups that are
present on the chondroitin and keratan sulfate on GAGs22. It is
possible that the extensive cross-linking that occurs during
formalin ﬁxation22 leads to a decrease in the maximal possible
ioxaglate diffusion because of the tighter extracellular matrix of theosteochondral tissue. This explanation could relate to our results of
lower attenuation levels in ﬁxed tissue despite the similar GAG
contents in fresh and ﬁxed samples. However, this issuewill have to
be addressed in future research.
One ﬁnal possible explanation for the differences in attenuation
is that residual formalin interacts with ioxaglate, leading to a lower
concentration of the contrast agent in the ﬁxed tissue. Therewas no
precipitate formed in the incubation tubes (both fresh and ﬁxed
samples), thus at least a precipitation reaction can be ruled out.
Additionally, pilot studies showed that attenuation levels for ﬁxed
tissues remained lower than fresh tissues following a 24 h PBS
wash after ﬁxation (to remove any residual formalin) and before
a second scan (data not shown). Thus, residual formalin does not
likely explain the differences we have measured.
This research has focused on bovine cartilage explants, which
could have implications for EPIC-mCT studies on cartilage from
different species. Bovine cartilage is a relatively thick tissue when
compared to cartilage from smaller animal models, thus zonal
variations are more easily discerned than in small animal models.
However, previous research has shown that the zonal GAG distri-
bution can be studied in thin cartilage samples from small animals
using EPIC-mCT14,15,17. Changes to staining protocols, such as short-
ening ioxaglate incubation time, can be made for thin cartilage
specimens, since less time is required for equilibration of the
contrast agent. Given that histological staining protocols, such as
Safranin O, work well on ﬁxed tissues irrespective of cartilage
thickness, it is likely that ﬁxed thin cartilage tissue will behave
similarly to those tissues studied here when using EPIC-mCT. None-
theless, further research is required to conﬁrm this assumption.
Besides EPIC-mCT, the MRI-based technique, dGEMRIC has also
been used to non-destructively quantify GAG content in fresh and
ﬁxed articular cartilage23. dGEMRIC and EPIC-mCTare both based on
the principle of a contrast agent that is distributed throughout the
cartilage in an inverse relationship to the concentration of
GAGs13,15. One of the main differences between dGEMRIC and EPIC-
mCT is their application in research settings. dGEMRIC has already
been successfully used in vivo24,25, whereas EPIC-mCT has only been
used ex vivo as there are concerns using this technique regarding
the radiation exposure and the high amounts of contrast agent that
will have to be administered12,14,15,17. Therefore it seems less likely
for EPIC-mCT to be implemented in clinical diagnostics. However,
EPIC-mCT in ex vivo cartilage imaging of small samples is possibly
more relevant than dGEMRIC due to the lower resolution of MRI-
generated images when scanning small samples ex vivo, unavoid-
ably this leads to unclear images of small cartilage samples.
Another difference is that ﬁxation of cartilage appears not to affect
GAG quantiﬁcation in dGEMRIC23, whereas our results demonstrate
a signiﬁcant reduction of the average attenuation using EPIC-mCT
imaging. Dugar et al. performed dGEMRIC imaging on ﬁxed bovine
and human tissue. They reported that ﬁxation “had a very modest,
if any, effect” on dGEMRIC imaging of bovine and human cartilage
tissue23. The results of our study however show a signiﬁcant
difference in cartilage attenuation after formalin ﬁxation of bovine
cartilage when using EPIC-mCT imaging. This will inevitably inﬂu-
ence the quantiﬁcation of GAGs in the tissue.
Despite the differences between attenuation levels of fresh and
ﬁxed tissue, the use of EPIC-mCT to non-destructively determine
the local distribution of GAG content in cartilage samples remains
a valid and promising technique. As we have shown, there is no
change in GAG content after ﬁxation; therefore we believe that the
correlation between X-ray attenuation and GAG content is
different for fresh and ﬁxed samples. This should be taken into
account and adjusted accordingly when quantifying GAG concen-
trations of both fresh and ﬁxed cartilage samples using EPIC-mCT
imaging.
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